Trial Profile
A Prospective, Observational, Drug Utilization Study of Subjects Taking Truvada for Pre-exposure Prophylaxis in the USA
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Emtricitabine/tenofovir disoproxil fumarate (Primary)
- Indications HIV infections
- Focus Therapeutic Use
- Sponsors Gilead Sciences
- 26 Mar 2018 Status changed from active, no longer recruiting to completed.
- 12 Feb 2018 Planned End Date changed from 1 Dec 2017 to 1 Jun 2018.
- 12 Feb 2018 Planned primary completion date changed from 1 Dec 2017 to 1 Jun 2018.